{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:43:41Z","timestamp":1789685021643,"version":"4.0.1"},"reference-count":78,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2018,7,27]],"date-time":"2018-07-27T00:00:00Z","timestamp":1532649600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Malignant mesothelioma (MM), a rare and severe cancer, mainly caused as a result of past-asbestos exposure, is presently a public health concern. Current molecular studies aim to improve the outcome of the disease, providing efficient therapies based on the principles of precision medicine. To model the molecular profile of human malignant mesothelioma, animal models have been developed in rodents, wild type animals and genetically engineered mice harbouring mutations in tumour suppressor genes, especially selecting genes known to be inactivated in human malignant mesothelioma. Animals were either exposed or not exposed to asbestos or to other carcinogenic fibres, to understand the mechanism of action of fibres at the molecular level, and the role of the selected genes in mesothelial carcinogenesis. The aim of the manuscript was to compare mesothelioma models to human malignant mesothelioma and to specify the clue genes playing a role in mesothelial carcinogenesis. Collectively, MM models recapitulate the clinical features of human MM. At least two altered genes are needed to induce malignant mesothelioma in mice. Two pathways regulated by Cdkn2a and Trp53 seem independent key players in mesothelial carcinogenesis. Other genes and pathways appear as bona fide modulators of the neoplastic transformation.<\/jats:p>","DOI":"10.3390\/ijms19082191","type":"journal-article","created":{"date-parts":[[2018,7,27]],"date-time":"2018-07-27T12:20:03Z","timestamp":1532694003000},"page":"2191","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Mesotheliomas in Genetically Engineered Mice Unravel Mechanism of Mesothelial Carcinogenesis"],"prefix":"10.3390","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5823-7404","authenticated-orcid":false,"given":"Didier","family":"Jean","sequence":"first","affiliation":[{"name":"Inserm, UMR-1162, G\u00e9nomique Fonctionnelle des Tumeurs Solides, F-75010 Paris, France"},{"name":"Universit\u00e9 Paris Descartes, Labex Immuno-Oncologie, Sorbonne Paris Cit\u00e9, F-75000 Paris, France"},{"name":"Institut Universitaire d\u2019H\u00e9matologie, Universit\u00e9 Paris Diderot, Sorbonne Paris Cit\u00e9, F-75010 Paris, France"},{"name":"Universit\u00e9 Paris 13, Sorbonne Paris Cit\u00e9, F-93206 Saint-Denis, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Claude","family":"Jaurand","sequence":"additional","affiliation":[{"name":"Inserm, UMR-1162, G\u00e9nomique Fonctionnelle des Tumeurs Solides, F-75010 Paris, France"},{"name":"Universit\u00e9 Paris Descartes, Labex Immuno-Oncologie, Sorbonne Paris Cit\u00e9, F-75000 Paris, France"},{"name":"Institut Universitaire d\u2019H\u00e9matologie, Universit\u00e9 Paris Diderot, Sorbonne Paris Cit\u00e9, F-75010 Paris, France"},{"name":"Universit\u00e9 Paris 13, Sorbonne Paris Cit\u00e9, F-93206 Saint-Denis, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,7,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"170098","DOI":"10.1183\/16000617.0098-2017","article-title":"Drug repurposing in malignant pleural mesothelioma: A breath of fresh air?","volume":"27","author":"Boyer","year":"2018","journal-title":"Eur. Respir. Rev."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1158\/1078-0432.CCR-16-0844","article-title":"Patient-Derived Xenograft Establishment from Human Malignant Pleural Mesothelioma","volume":"23","author":"Wu","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"248","DOI":"10.21037\/tlcr.2017.04.12","article-title":"In vitro experimental models of mesothelioma revisited","volume":"6","author":"Singh","year":"2017","journal-title":"Transl. Lung Cancer Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/MCP.0000000000000489","article-title":"Updates in the diagnosis and treatment of malignant pleural mesothelioma","volume":"24","author":"Katzman","year":"2018","journal-title":"Curr. Opin. Pulm. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1136\/oemed-2017-104802","article-title":"Dose-time response association between occupational asbestos exposure and pleural mesothelioma: Authors\u2019 response","volume":"75","author":"Lacourt","year":"2018","journal-title":"Occup. Environ. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jtho.2018.02.021","article-title":"Progress in the Management of Malignant Pleural Mesothelioma in 2017","volume":"13","author":"McCambridge","year":"2018","journal-title":"J. Thorac. Oncol."},{"key":"ref_7","first-page":"7658","article-title":"Molecular changes of malignant mesothelioma in the testis and their impact on prognosis: Analyses of two cases","volume":"9","author":"Serio","year":"2016","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"5629","DOI":"10.3390\/ijerph10115629","article-title":"Domestic asbestos exposure: A review of epidemiologic and exposure data","volume":"10","author":"Goswami","year":"2013","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"234","DOI":"10.21037\/atm.2017.03.74","article-title":"Environmental asbestos exposure and risk of mesothelioma","volume":"5","author":"Noonan","year":"2017","journal-title":"Ann. Transl. Med."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Serio, G., Pezzuto, F., Marzullo, A., Scattone, A., Cavone, D., Punzi, A., Fortarezza, F., Gentile, M., Buonadonna, A.L., and Barbareschi, M. (2017). Peritoneal Mesothelioma with Residential Asbestos Exposure. Report of a Case with Long Survival (Seventeen Years) Analyzed by Cgh-Array. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18081818"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"15692","DOI":"10.1007\/s11356-018-1618-x","article-title":"Environmental asbestos exposure and mesothelioma cases in Bari, Apulia region, southern Italy: A national interest site for land reclamation","volume":"25","author":"Vimercati","year":"2018","journal-title":"Environ. Sci. Pollut."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.5858\/arpa.2017-0124-RA","article-title":"Guidelines for Pathologic Diagnosis of Malignant Mesothelioma 2017 Update of the Consensus Statement From the International Mesothelioma Interest Group","volume":"142","author":"Husain","year":"2018","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Light, R.W., and GaryLee, Y.C. (2016). Mesothelial cells and pleural immunology. Textbook of Pleural Diseases, CRC Press. [3nd ed.].","DOI":"10.1201\/b19146-9"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0272-5231(05)70074-5","article-title":"Anatomy of the pleura","volume":"19","author":"Wang","year":"1998","journal-title":"Clin. Chest Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1089\/lrb.2014.0009","article-title":"Lymphatic Stomata in the Adult Human Pulmonary Ligament","volume":"13","author":"Oshiro","year":"2015","journal-title":"Lymphat. Res. Biol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/10937404.2011.556049","article-title":"Non-neoplastic and neoplastic pleural endpoints following fiber exposure","volume":"14","author":"Broaddus","year":"2011","journal-title":"J. Toxicol. Environ. Health B Crit. Rev."},{"key":"ref_17","first-page":"358","article-title":"Pleural lymphatics and pleural diseases related to fibres","volume":"69","author":"Jaurand","year":"2013","journal-title":"Rev. Pneumol. Clin."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Oehl, K., Vrugt, B., Opitz, I., and Meerang, M. (2018). Heterogeneity in Malignant Pleural Mesothelioma. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19061603"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"113673","DOI":"10.18632\/oncotarget.22817","article-title":"Large-scale copy number analysis reveals variations in genes not previously associated with malignant pleural mesothelioma","volume":"8","author":"Hylebos","year":"2017","journal-title":"Oncotarget"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"277","DOI":"10.5858\/arpa.2011-0215-RA","article-title":"Molecular changes in mesothelioma with an impact on prognosis and treatment","volume":"136","author":"Jean","year":"2012","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1158\/1078-0432.CCR-16-1971","article-title":"Co-occurring Mutations of Tumor Suppressor Genes, LATS2 and NF2, in Malignant Pleural Mesothelioma","volume":"23","author":"Tranchant","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/ng.3520","article-title":"Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations","volume":"48","author":"Bueno","year":"2016","journal-title":"Nat. Genet."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.ajpath.2010.10.039","article-title":"Syntenic relationships between genomic profiles of fiber-induced murine and human malignant mesothelioma","volume":"176","author":"Jean","year":"2011","journal-title":"Am. J. Pathol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1080\/15384047.2016.1145850","article-title":"Genome-wide analysis of abdominal and pleural malignant mesothelioma with DNA arrays reveals both common and distinct regions of copy number alteration","volume":"17","author":"Borczuk","year":"2016","journal-title":"Cancer Biol. Ther."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3748","DOI":"10.1038\/onc.2013.351","article-title":"Overexpression and promoter mutation of the TERT gene in malignant pleural mesothelioma","volume":"33","author":"Tallet","year":"2014","journal-title":"Oncogene"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"S369","DOI":"10.21037\/jtd.2017.10.158","article-title":"Overexpressed genes in malignant pleural mesothelioma: Implications in clinical management","volume":"10","author":"Barone","year":"2018","journal-title":"J. Thorac. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1097\/JTO.0000000000000202","article-title":"Frequent coamplification and cooperation between C-MYC and PVT1 oncogenes promote malignant pleural mesothelioma","volume":"9","author":"Riquelme","year":"2014","journal-title":"J. Thorac. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.anndiagpath.2014.02.005","article-title":"Elevated PDGFRB gene copy number gain is prognostic for improved survival outcomes in resected malignant pleural mesothelioma","volume":"18","author":"Tsao","year":"2014","journal-title":"Ann. Diagn. Pathol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.lungcan.2015.11.002","article-title":"Non-coding RNA repertoires in malignant pleural mesothelioma","volume":"90","author":"Quinn","year":"2015","journal-title":"Lung Cancer"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.gde.2018.01.001","article-title":"Emerging roles of microRNAs in cancer","volume":"48","author":"Vannini","year":"2018","journal-title":"Curr. Opin. Genet. Dev."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1158\/0008-5472.CAN-08-2586","article-title":"Epigenetic profiles distinguish pleural mesothelioma from normal pleura and predict lung asbestos burden and clinical outcome","volume":"69","author":"Christensen","year":"2009","journal-title":"Cancer Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/carcin\/bgn059","article-title":"Asbestos exposure predicts cell cycle control gene promoter methylation in pleural mesothelioma","volume":"29","author":"Christensen","year":"2008","journal-title":"Carcinogenesis"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.18632\/oncotarget.13174","article-title":"Malignant pleural mesothelioma and mesothelial hyperplasia: A new molecular tool for the differential diagnosis","volume":"8","author":"Bruno","year":"2017","journal-title":"Oncotarget"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1165\/rcmb.2009-0060OC","article-title":"MicroRNA signature of malignant mesothelioma with potential diagnostic and prognostic implications","volume":"42","author":"Busacca","year":"2010","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_35","first-page":"1031","article-title":"MicroRNAs in mesothelioma: From tumour suppressors and biomarkers to therapeutic targets","volume":"7","author":"Reid","year":"2015","journal-title":"J. Thorac. Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1038\/s41598-017-02694-0","article-title":"Deregulation of miRNAs in malignant pleural mesothelioma is associated with prognosis and suggests an alteration of cell metabolism","volume":"7","author":"Melaiu","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_37","unstructured":"Mineo, T.C. (2015). Biomolecular Pathways and Malignant Pleural Mesothelioma. Malignant Pleural Mesothelioma: Present Status and Future Directions, Bentham Science Publishers."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1093\/carcin\/bgt166","article-title":"Molecular pathogenesis of malignant mesothelioma","volume":"34","author":"Sekido","year":"2013","journal-title":"Carcinogenesis"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"500","DOI":"10.3390\/genes6030500","article-title":"Hedgehog Signaling in Malignant Pleural Mesothelioma","volume":"6","author":"Opitz","year":"2015","journal-title":"Genes"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Gradilla, A.C., Sanchez-Hernandez, D., Brunt, L., and Scholpp, S. (2018). From top to bottom: Cell polarity in Hedgehog and Wnt trafficking. BMC Biol., 16.","DOI":"10.1186\/s12915-018-0511-x"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"14680","DOI":"10.18632\/oncotarget.24411","article-title":"Old Sonic Hedgehog, new tricks: A new paradigm in thoracic malignancies","volume":"9","author":"Leprieur","year":"2018","journal-title":"Oncotarget"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1093\/annonc\/mdu127","article-title":"Expression profiling stratifies mesothelioma tumors and signifies deregulation of spindle checkpoint pathway and microtubule network with therapeutic implications","volume":"25","author":"Suraokar","year":"2014","journal-title":"Ann. Oncol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1158\/1078-0432.CCR-13-2429","article-title":"Molecular classification of malignant pleural mesothelioma: Identification of a poor prognosis subgroup linked to the epithelial-to-mesenchymal transition","volume":"20","author":"Jaurand","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.5858\/arpa.2016-0073-OA","article-title":"Dataset for Reporting of Malignant Mesothelioma of the Pleura or Peritoneum: Recommendations From the International Collaboration on Cancer Reporting (ICCR)","volume":"140","author":"Churg","year":"2016","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_45","first-page":"32","article-title":"Peritoneal mesothelioma: A review","volume":"9","author":"Bridda","year":"2007","journal-title":"MedGenMed"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/modpathol.2016.188","article-title":"Genomic profiling of malignant peritoneal mesothelioma reveals recurrent alterations in epigenetic regulatory genes BAP1, SETD2, and DDX3X","volume":"30","author":"Joseph","year":"2017","journal-title":"Mod. Pathol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1001\/jamaoncol.2017.2918","article-title":"Identification of ALK Rearrangements in Malignant Peritoneal Mesothelioma","volume":"4","author":"Hung","year":"2018","journal-title":"JAMA Oncol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1177\/019262338701500205","article-title":"Spontaneous Mesotheliomas in Fischer Rats\u2014A Histological and Electron Microscopic Study","volume":"15","author":"Tanigawa","year":"1987","journal-title":"Toxicol. Pathol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1080\/10408444.2016.1174669","article-title":"The legacy of the F344 rat as a cancer bioassay model (a retrospective summary of three common F344 rat neoplasms)","volume":"46","author":"Maronpot","year":"2016","journal-title":"Crit. Rev. Toxicol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0940-2993(11)80407-0","article-title":"Frequency of spontaneous tumours in NMRI mice in 21-month studies","volume":"45","author":"Bomhard","year":"1993","journal-title":"Exp. Toxicol. Pathol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/ijc.2910100207","article-title":"Incidence of spontaneous neoplasms in breeding and retired breeder BALB-cCr mice throughout the natural life span","volume":"10","author":"Peters","year":"1972","journal-title":"Int. J. Cancer"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1293\/tox.24.169","article-title":"Mixed Type of Malignant Mesothelioma in an Aged Male ICR Mouse","volume":"24","author":"Shirai","year":"2011","journal-title":"J. Toxicol. Pathol."},{"key":"ref_53","unstructured":"IARC (1988). Man-made vitreous fibres and Radon. IARC Monogr. Eval. Carcinog. Risks Hum., 43, 1\u2013300."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1476-069X-13-59","article-title":"Quantification of short and long asbestos fibers to assess asbestos exposure: A review of fiber size toxicity","volume":"13","author":"Boulanger","year":"2014","journal-title":"Environ. Health"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/bjc.1969.70","article-title":"Mesotheliomas in rats following inoculation with asbestos","volume":"23","author":"Wagner","year":"1969","journal-title":"Br. J. Cancer"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Sneddon, S., Patch, A.M., Dick, I.M., Kazakoff, S., Pearson, J.V., Waddell, N., Allcock, R.J.N., Holt, R.A., Robinson, B.W.S., and Creaney, J. (2017). Whole exome sequencing of an asbestos-induced wild-type murine model of malignant mesothelioma. BMC Cancer, 17.","DOI":"10.1186\/s12885-017-3382-6"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1016\/j.cub.2017.09.007","article-title":"Long-Fiber Carbon Nanotubes Replicate Asbestos-Induced Mesothelioma with Disruption of the Tumor Suppressor Gene Cdkn2a (Ink4a\/Arf)","volume":"27","author":"Chernova","year":"2017","journal-title":"Curr. Biol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1038\/onc.2013.280","article-title":"Tsc1-Tp53 loss induces mesothelioma in mice, and evidence for this mechanism in human mesothelioma","volume":"33","author":"Guo","year":"2014","journal-title":"Oncogene"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ccr.2008.01.030","article-title":"A conditional mouse model for malignant mesothelioma","volume":"13","author":"Jongsma","year":"2008","journal-title":"Cancer Cell"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1158\/0008-5472.CAN-15-3371","article-title":"Bap1 Is a Bona Fide Tumor Suppressor: Genetic Evidence from Mouse Models Carrying Heterozygous Germline Bap1 Mutations","volume":"76","author":"Kadariya","year":"2016","journal-title":"Cancer Res."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Sementino, E., Menges, C.W., Kadariya, Y., Peri, S., Xu, J., Liu, Z., Wilkes, R.G., Cai, K.Q., Rauscher, F.J., and Klein-Szanto, A.J. (2018). Inactivation of Tp53 and Pten drives rapid development of pleural and peritoneal malignant mesotheliomas. J. Cell. Physiol.","DOI":"10.1002\/jcp.26830"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"3420","DOI":"10.1073\/pnas.0808816106","article-title":"Activated TNF-\u03b1\/NF-\u03baB signaling via down-regulation of Fas-associated factor 1 in asbestos-induced mesotheliomas from Arf knockout mice","volume":"106","author":"Altomare","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Altomare, D.A., Menges, C.W., Xu, J., Pei, J., Zhang, L., Tadevosyan, A., Neumann-Domer, E., Liu, Z., Carbone, M., and Chudoba, I. (2011). Losses of both products of the Cdkn2a\/Arf locus contribute to asbestos-induced mesothelioma development and cooperate to accelerate tumorigenesis. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0018828"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"8090","DOI":"10.1158\/0008-5472.CAN-05-2312","article-title":"A mouse model recapitulating molecular features of human mesothelioma","volume":"65","author":"Altomare","year":"2005","journal-title":"Cancer Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1093\/carcin\/bgm023","article-title":"Clinico-pathological features and somatic gene alterations in refractory ceramic fibre-induced murine mesothelioma reveal mineral fibre-induced mesothelioma identities","volume":"28","author":"Andujar","year":"2007","journal-title":"Carcinogenesis"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1038\/sj.onc.1206593","article-title":"Hemizygosity of N\u01922 is associated with increased susceptibility to asbestos-induced peritoneal tumours","volume":"22","author":"Lecomte","year":"2003","journal-title":"Oncogene"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1038\/onc.2015.243","article-title":"Minimal asbestos exposure in germline BAP1 heterozygous mice is associated with deregulated inflammatory response and increased risk of mesothelioma","volume":"35","author":"Napolitano","year":"2016","journal-title":"Oncogene"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/toxsci\/68.2.331","article-title":"Accelerated progression of asbestos-induced mesotheliomas in heterozygous p53+\/\u2212 mice","volume":"68","author":"Vaslet","year":"2002","journal-title":"Toxicol. Sci."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1158\/0008-5472.CAN-13-2062","article-title":"Tumor suppressor alterations cooperate to drive aggressive mesotheliomas with enriched cancer stem cells via a p53-miR-34a-c-Met axis","volume":"74","author":"Menges","year":"2014","journal-title":"Cancer Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2131\/jts.33.105","article-title":"Induction of mesothelioma in p53+\/\u2212 mouse by intraperitoneal application of multi-wall carbon nanotube","volume":"33","author":"Takagi","year":"2008","journal-title":"J. Toxicol. Sci."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1158\/1940-6207.CAPR-15-0347","article-title":"Inflammation-Related IL1beta\/IL1R Signaling Promotes the Development of Asbestos-Induced Malignant Mesothelioma","volume":"9","author":"Kadariya","year":"2016","journal-title":"Cancer Prev. Res."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"10786","DOI":"10.1158\/0008-5472.CAN-05-4668","article-title":"A novel SV40 TAg transgenic model of asbestos-induced mesothelioma: Malignant transformation is dose dependent","volume":"66","author":"Robinson","year":"2006","journal-title":"Cancer Res."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Robinson, C., Dick, I.M., Wise, M.J., Holloway, A., Diyagama, D., Robinson, B.W., Creaney, J., and Lake, R.A. (2015). Consistent gene expression profiles in MexTAg transgenic mouse and wild type mouse asbestos-induced mesothelioma. BMC Cancer, 15.","DOI":"10.1186\/s12885-015-1953-y"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.4161\/cc.4.12.2300","article-title":"Similar tumor suppressor gene alteration profiles in asbestos-induced murine and human mesothelioma","volume":"4","author":"Lecomte","year":"2005","journal-title":"Cell Cycle"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1038\/s41388-018-0153-z","article-title":"How asbestos drives the tissue towards tumors: YAP activation, macrophage and mesothelial precursor recruitment, RNA editing, and somatic mutations","volume":"37","author":"Rehrauer","year":"2018","journal-title":"Oncogene"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"4388","DOI":"10.1158\/0008-5472.CAN-14-1328","article-title":"Germline mutation of Bap1 accelerates development of asbestos-induced malignant mesothelioma","volume":"74","author":"Xu","year":"2014","journal-title":"Cancer Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/nature08768","article-title":"Signatures of mutation and selection in the cancer genome","volume":"463","author":"Bignell","year":"2010","journal-title":"Nature"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3109\/10408444.2012.756456","article-title":"Oxidatively damaged DNA in animals exposed to particles","volume":"43","author":"Moller","year":"2013","journal-title":"Crit. Rev. Toxicol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/19\/8\/2191\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:14:44Z","timestamp":1760195684000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/19\/8\/2191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,27]]},"references-count":78,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2018,8]]}},"alternative-id":["ijms19082191"],"URL":"https:\/\/doi.org\/10.3390\/ijms19082191","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,27]]}}}